Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.23736/S0375-9393.23.17321-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Remimazolam: a new reminder to keep our guard up.
Minerva Anestesiol
June 2023
Department of Anaesthesiology and Perioperative Medicine, Complejo Hospitalario Universitario de A Coruña (CHUAC), A Coruña, Spain.
Laryngeal edema following remimazolam-induced anaphylaxis: a rare clinical manifestation.
BMC Anesthesiol
March 2023
Department of Anesthesiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Background: Remimazolam is an ultra-short-acting intravenous benzodiazepine, which has been used as sedative/anesthetic in procedural sedation and anesthesia. Although peri-operative anaphylaxis due to remimazolam has been reported recently, the spectrum of the allergic reactions is still not fully known.
Case Presentation: We describe a case of anaphylaxis following remimazolam administration in a male patient undergoing colonoscopy under procedural sedation.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!